MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash in bank
$2,722,451
Prepaid expenses
$90,643
Vat receivable
$44,043
Inventories
$1,075
Intangible assets, net
$2,093,228
Fixed assets, net
$51,407
Total current assets
$2,858,212
Total long-term
assets
$2,144,635
Total assets
$5,002,847
Accumulated deficit
-$11,324,625
Foreign currency
translation adjustment
-$221,172
Total liabilities and
stockholders deficit
$5,002,847
Total stockholders
deficit
-$4,700,565
Additional paid in capital
$6,845,036
Common stock, 0.0001
par value,...
$195
Preferred stock,
value-Series C1Convertible...
$1
Total liabilities
$9,703,412
Total current
liabilities
$9,703,412
Derivative liabilities
$3,656,394
Notes payable, net
$3,156,052
Accounts payable
$1,641,443
Loans payable,
related parties
$841,548
Accrued liabilities
$407,975
Back
Back
Balance Sheet
source: myfinsight.com
Protagenic Therapeutics, Inc. new (PTIX)
Protagenic Therapeutics, Inc. new (PTIX)